 |
|
 |
- November 20, 2008 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Presentation |
|
"The ORIGIN Study"Prof. Hertzel Gerstein (biography)
English - 2005-04-16 - 27 minutes
|
 | (22 slides) |
Summary :
In this presentation Prof. Gerstein describes the rationale and design of the ORIGIN (Outcome Reduction with an Initial Glargine INtervention) trial.
ORIGIN is a large, international, multicentre trial investigating in high risk people with IFG, IGT or early diabetes, whether insulin replacement therapy targeting fasting normoglycaemia with insulin glargine reduces the risk of CV events more than standard approaches to dysglycaemia, and secondly whether omega-3 polyunsaturated fatty acid supplements reduce the risk of CV events.
Copyright © 2005 E-MedHosting.com Inc.
Learning objectives :
After viewing this presentation the participant will be able to discuss:
- The rationale and design of the ORIGIN trial
|
|
|
|
|
|
| Search our website |
 |
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
| Social |
|
| |
Let others know about this presentation.
|
|
|
|
